KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 201 filers reported holding KARUNA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $419 | +15.4% | 1,930 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $363 | -8.3% | 2,000 | -0.8% | 0.00% | 0.0% |
| Q4 2022 | $396 | -99.9% | 2,016 | -1.9% | 0.00% | -33.3% |
| Q3 2022 | $462,000 | -43.2% | 2,056 | -68.0% | 0.00% | -25.0% |
| Q2 2022 | $813,000 | +195.6% | 6,423 | +195.7% | 0.00% | +300.0% |
| Q1 2022 | $275,000 | +1.5% | 2,172 | +5.1% | 0.00% | 0.0% |
| Q4 2021 | $271,000 | +7.1% | 2,067 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $253,000 | +8.1% | 2,067 | +0.7% | 0.00% | 0.0% |
| Q2 2021 | $234,000 | -2.1% | 2,052 | +3.2% | 0.00% | 0.0% |
| Q1 2021 | $239,000 | +15.5% | 1,988 | -2.5% | 0.00% | 0.0% |
| Q4 2020 | $207,000 | – | 2,038 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $142,043,933 | 58.49% |
| Nan Fung Group Holdings Ltd | 225,688 | $40,993,968 | 27.90% |
| Sofinnova Investments, Inc. | 1,773,124 | $322,070,243 | 20.60% |
| Artia Global Partners LP | 88,831 | $16,135,263 | 5.96% |
| DAFNA Capital Management LLC | 78,573 | $14,272,000 | 4.28% |
| First Light Asset Management, LLC | 243,675 | $44,261,127 | 3.98% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $3,966,473 | 2.74% |
| Sands Capital Ventures, LLC | 58,895 | $10,697,688 | 2.64% |
| ARCH Venture Management, LLC | 30,000 | $5,449,200 | 2.63% |
| Logos Global Management LP | 100,000 | $18,164,000 | 2.60% |